Phylloquinone Market Size, Share & Trends Analysis Report By Product (Food Grade, Pharma Grade, Other), By Applications (Food, Pharmaceutical, Other), By End Use, By Region, and Segment Forecasts - 2035

Phylloquinone Market Overview

The global phylloquinone market size was valued at USD 91.25 million in 2025 and is projected to grow from USD 96.82 million in 2026 to USD 176.91 million by 2035, exhibiting a CAGR of 6.1% during the forecast period.

The phylloquinone market is expanding as demand rises for vitamin K1 ingredients across Food, Pharmaceutical, and Other applications requiring standardized potency, controlled purity, and dependable formulation performance. Market activity is projected to increase approximately 93.9% between 2025 and 2035, supported by growing micronutrient awareness, fortified product development, pharmaceutical manufacturing, and increased use of accurately standardized vitamin ingredients. Pharma Grade is estimated to account for approximately 56% of product demand because pharmaceutical applications require tighter impurity limits, validated potency, and greater batch consistency. Food Grade represents around 34%, while Other grades contribute approximately 10%. Pharmaceutical applications account for an estimated 52% of total demand, Food represents approximately 36%, and Other applications around 12%. Manufacturers are increasingly investing in purification efficiency, oxidation control, encapsulation, stability enhancement, analytical testing, and controlled storage systems to improve phylloquinone performance throughout processing and product shelf life.

The United States represents an important phylloquinone consumption market because of its established pharmaceutical manufacturing base, nutritional ingredient sector, fortified food industry, and broad use of standardized vitamin formulations. The country is estimated to account for approximately 19% of global demand, with Pharmaceutical applications representing around 55% of domestic consumption and Food applications contributing approximately 34%. Pharma Grade accounts for approximately 59% of U.S. product demand as manufacturers prioritize verified potency, impurity control, documentation, and manufacturing consistency. Approximately 54% of larger ingredient buyers emphasize analytical verification, storage stability, supplier qualification, and traceable production when selecting vitamin K1 inputs. Continued development of fortified foods, specialized nutritional products, and pharmaceutical formulations is expected to support steady U.S. demand through 2035.

• 

  Download Free sample to learn more about this report.

Key Findings

• Leading Product Type: Pharma Grade is expected to remain the dominant product type with approximately 56% market share, supported by stringent potency, impurity-control, documentation, and pharmaceutical manufacturing requirements.
• Leading Application: Pharmaceutical is projected to lead application demand with approximately 52% share, reflecting sustained requirements for standardized vitamin K1 ingredients across clinically oriented formulations and healthcare manufacturing.
• Leading Region: Asia-Pacific is expected to hold approximately 41% of global demand, supported by expanding pharmaceutical manufacturing, ingredient processing capabilities, and growing nutritional product consumption.
• Fastest Growing Region: Asia-Pacific is projected to record the strongest expansion, with approximately 43% of new capacity-oriented investment focused on purification, pharmaceutical-grade processing, formulation technology, and quality-control infrastructure.
• Technology Trend: Encapsulation and stabilization technologies are gaining importance, with approximately 35% of technical development activity focused on protecting phylloquinone against oxidation, light exposure, and formulation-related degradation.
• Market Driver: Expanding demand for standardized vitamin ingredients remains the strongest growth catalyst, accounting for approximately 62% of underlying market momentum across Pharmaceutical, Food, and Other applications.
• Competitive Landscape: Leading producers are strengthening processing and quality capabilities, with approximately 42% of competitive investment directed toward purification, analytical testing, stability improvement, and manufacturing modernization.
• Future Outlook: Market activity is projected to increase approximately 82.7% between 2026 and 2035 as pharmaceutical manufacturing, food fortification, and specialized nutritional formulations continue expanding.

Latest Trends

A major trend in the phylloquinone market is the increasing use of stabilization and delivery technologies designed to protect vitamin K1 from oxidation, light exposure, heat, and interactions with other formulation ingredients. Approximately 35% of current technical development activity is focused on encapsulation, protective carriers, improved emulsification, controlled particle characteristics, and packaging systems that increase stability throughout storage and processing. Pharma Grade, which represents approximately 56% of product demand, remains the primary focus for these technologies because pharmaceutical-oriented customers require reliable potency and reproducible performance. Around 44% of larger formulators increasingly evaluate suppliers on stability data and analytical consistency in addition to nominal purity. These requirements are encouraging manufacturers to move beyond conventional ingredient supply toward application-specific phylloquinone systems designed for greater processing resilience and longer shelf-life performance.

Another important trend is the expansion of vitamin K1 use in fortified and specialized nutritional products alongside traditional Pharmaceutical applications. Food accounts for approximately 36% of application demand and is becoming more important as manufacturers seek controlled micronutrient inclusion in formulated products. Approximately 39% of product-development activity is increasingly associated with fortification compatibility, improved dispersibility, standardized potency, or specialized nutritional formulation. Pharmaceutical applications remain dominant at approximately 52%, but suppliers are increasingly diversifying across food and other nutritional uses to reduce dependence on a single end market. Quality documentation, contaminant control, analytical testing, and stable supply are becoming stronger purchasing considerations, particularly as the overall market advances at a projected 6.1% CAGR through 2035.

Market Dynamics

Driver

""Growing demand for standardized vitamin ingredients is strengthening phylloquinone consumption.""

Increasing demand for accurately standardized vitamin ingredients across pharmaceutical and food manufacturing remains the principal driver of the phylloquinone market. Approximately 62% of underlying market momentum is linked to greater micronutrient awareness, expanded use of formulated nutritional products, and pharmaceutical demand for controlled vitamin K1 inputs. Pharmaceutical applications account for approximately 52% of total consumption, providing the largest recurring demand base, while Food contributes around 36%. Pharma Grade represents approximately 56% of product demand because manufacturers require precise potency, tighter impurity limits, and dependable batch consistency. Market activity is projected to increase approximately 93.9% between 2025 and 2035 as vitamin formulation becomes more technically standardized and manufacturers strengthen quality requirements across regulated and nutrition-oriented products.

Restraint

""Sensitivity to oxidation and light can complicate storage and formulation performance.""

Phylloquinone is sensitive to environmental and processing conditions, creating technical constraints during manufacturing, storage, transportation, and finished-product formulation. Approximately 37% of formulation-related difficulties are associated with oxidation, light exposure, temperature variation, and maintaining stable potency over time. Around 30% of supplier qualification requirements are linked to impurity control, analytical verification, storage documentation, and packaging performance. Pharma Grade products require particularly rigorous control, which can increase processing complexity and production costs. Food Grade applications may also require specialized dispersion or protective systems to maintain consistent vitamin delivery throughout shelf life. These technical considerations can limit adoption among smaller manufacturers even as overall market demand expands at approximately 6.1% annually.

Opportunity

""Food fortification and advanced stabilization create attractive new growth opportunities.""

Food fortification and application-specific delivery systems provide significant opportunities for phylloquinone manufacturers seeking to diversify beyond conventional pharmaceutical demand. Approximately 42% of competitive investment is directed toward purification, analytical testing, stabilization, and manufacturing modernization. Food applications, representing approximately 36% of demand, provide opportunities for stabilized Food Grade phylloquinone that can be incorporated into formulated products without substantial potency loss. Asia-Pacific offers additional potential because approximately 43% of new capacity-oriented investment is concentrated in regional processing, quality-control, and formulation capabilities. Suppliers that combine standardized potency with encapsulation, oxidation protection, and application-specific technical support are positioned to capture higher-value opportunities through 2035.

Challenge

""Maintaining potency consistency across different formulations remains technically demanding.""

A central challenge for phylloquinone manufacturers is maintaining stable and reproducible potency across pharmaceutical, food, and other formulation environments. Approximately 34% of technical customer concerns involve stability, dosage consistency, ingredient compatibility, and storage performance. Application diversity adds complexity because Pharmaceutical represents approximately 52% of demand, Food accounts for 36%, and Other applications contribute around 12%, with each category requiring different quality and formulation characteristics. Manufacturers must also manage raw-material quality, process control, packaging, and transportation conditions while meeting increasingly strict buyer specifications. Sustaining a projected 6.1% CAGR through 2035 will require stronger stabilization technologies, analytical methods, quality systems, and application-specific development capabilities.

• 

  Download Free sample to learn more about this report.

Segmentation Analysis

The phylloquinone market is segmented by product grade and application, with purchasing decisions influenced by purity, potency consistency, stability, formulation compatibility, regulatory requirements, storage conditions, and end-use performance. Pharma Grade is estimated to account for approximately 56% of product demand, followed by Food Grade at around 34% and Other grades at approximately 10%. By application, Pharmaceutical represents approximately 52% of total demand, Food accounts for around 36%, and Other applications contribute approximately 12%. This structure reflects the importance of regulated pharmaceutical use while highlighting growing demand for standardized vitamin K1 ingredients in fortified and specialized food formulations.

By Types

Food Grade: Food Grade phylloquinone accounts for approximately 34% of product demand and is increasingly used in fortified foods, nutritional formulations, and other applications requiring controlled vitamin K1 inclusion. Around 41% of buyers in this category prioritize dispersibility, potency consistency, and storage stability because vitamin degradation can affect finished-product performance. Manufacturers are improving encapsulation, emulsification, carrier selection, and packaging protection to enhance stability during processing and shelf life. Demand is expected to strengthen through 2035 as food producers expand micronutrient fortification and seek standardized ingredients that can be integrated into high-volume manufacturing without compromising product quality.

Pharma Grade: Pharma Grade represents approximately 56% of product demand and remains the leading category because pharmaceutical manufacturing requires tighter impurity limits, validated potency, reproducible batch quality, and extensive documentation. Approximately 53% of pharmaceutical-oriented buyers emphasize analytical verification, storage stability, impurity control, and manufacturing traceability when qualifying suppliers. Producers serving this segment invest heavily in purification, controlled processing environments, advanced analytical testing, and protective packaging. The segment is expected to retain its leading position through 2035 as pharmaceutical demand for standardized vitamin K1 ingredients continues to expand across clinically oriented and regulated formulations.

Other: Other grades account for approximately 10% of product demand and serve specialized formulations, research-oriented uses, and customized applications outside mainstream Food Grade and Pharma Grade categories. Around 29% of demand in this segment is linked to tailored purity, concentration, or formulation requirements. Suppliers serving this category typically compete through flexibility, smaller production batches, technical support, and customized delivery formats. Although comparatively limited in volume, the segment provides opportunities for specialized product development and differentiated application support.

By Applications

Food: Food applications account for approximately 36% of market demand and are supported by increasing use of phylloquinone in fortified foods, specialized nutritional products, and other micronutrient-enhanced formulations. Approximately 40% of food-focused buyers emphasize stability, uniform dispersion, and accurate vitamin concentration because these factors influence product consistency throughout processing and storage. Food Grade material is particularly important in this segment, while encapsulated and stabilized forms are gaining attention where formulation conditions create greater exposure to heat, light, or oxidation. Demand is expected to expand steadily as nutrition-focused product development increases.

Pharmaceutical: Pharmaceutical applications represent approximately 52% of total demand and remain the largest end-use segment. Around 55% of buyers in this application prioritize potency accuracy, impurity control, documented manufacturing quality, and storage performance. Pharma Grade phylloquinone is preferred because regulated formulations require dependable composition and batch consistency. Producers are increasingly strengthening analytical testing, packaging protection, and process validation to meet these requirements. The segment is expected to remain dominant through 2035 as pharmaceutical manufacturers continue using standardized vitamin K1 ingredients across multiple clinically oriented formulations.

Other: Other applications account for approximately 12% of market demand and include specialized nutritional, technical, and customized uses outside mainstream food and pharmaceutical channels. Around 31% of development activity in this category focuses on improved stability, concentration control, or application-specific delivery formats. The segment provides opportunities for suppliers able to offer flexible specifications, customized packaging, and technical formulation support. Demand is expected to grow gradually as specialized micronutrient products become more diverse.

• 

  Download Free sampleto learn more about this report.

Regional Outlook

North America

North America accounts for approximately 22% of global phylloquinone demand, supported by established pharmaceutical manufacturing, nutritional ingredient production, fortified foods, and strong quality requirements across vitamin formulations. The United States represents the majority of regional consumption, with Pharmaceutical applications accounting for approximately 55% of demand and Food contributing around 34%. Approximately 54% of larger buyers emphasize analytical verification, storage stability, supplier qualification, and traceable production when selecting vitamin K1 ingredients. Pharma Grade remains the dominant product category because pharmaceutical and specialized nutritional manufacturers require precise potency and controlled quality.

Regional development is increasingly focused on improved stabilization, encapsulation, and documentation. Around 42% of North American technical investment is associated with oxidation protection, delivery systems, analytical testing, and packaging performance. Food Grade demand is also expanding as manufacturers increase fortification across selected nutrition-oriented products. North America is expected to maintain stable growth through 2035 as product quality, formulation consistency, and reliable domestic supply remain central purchasing criteria.

Europe

Europe represents approximately 24% of global phylloquinone demand and maintains strong requirements for standardized vitamin ingredients across Pharmaceutical and Food applications. Pharmaceutical uses account for approximately 53% of regional demand, while Food represents around 35%. Approximately 57% of larger European buyers prioritize documented purity, traceability, potency verification, and storage stability when qualifying suppliers. These requirements support demand for Pharma Grade material and encourage manufacturers to invest in rigorous quality-control systems.

Food Grade phylloquinone is also gaining importance as European manufacturers expand micronutrient fortification and specialized nutritional product development. Around 44% of regional technical initiatives focus on stability enhancement, encapsulation, and formulation compatibility. Europe is expected to remain a high-value market through 2035 as pharmaceutical standards remain stringent and food manufacturers continue developing products with precisely controlled micronutrient content.

Asia-Pacific

Asia-Pacific leads the global phylloquinone market with approximately 41% share, supported by expanding pharmaceutical manufacturing, ingredient processing, food fortification, and growing healthcare demand across China, India, Japan, South Korea, and Southeast Asia. Pharmaceutical applications account for approximately 51% of regional demand, while Food represents around 38%. Approximately 43% of new capacity-oriented investment is concentrated in purification, quality-control infrastructure, formulation technology, and pharmaceutical-grade production capabilities.

Pharma Grade represents approximately 54% of regional product demand, while Food Grade accounts for around 36%. Approximately 46% of regional producers are improving analytical testing, process automation, purification efficiency, and protective packaging to strengthen domestic and export competitiveness. Asia-Pacific is expected to remain the fastest-growing region through 2035 as pharmaceutical output, nutrition-focused food manufacturing, and local vitamin ingredient capabilities continue expanding.

Latin America

Latin America accounts for approximately 7% of global phylloquinone demand, with Brazil and Mexico serving as the principal consumption centers. Pharmaceutical applications represent approximately 50% of regional demand, while Food contributes around 37%. Approximately 39% of purchasing activity is influenced by imported standardized vitamin ingredients, reflecting more limited local production compared with Asia-Pacific, Europe, or North America. Buyers increasingly emphasize dependable potency and supplier documentation as pharmaceutical and food manufacturing becomes more technically standardized.

Pharma Grade accounts for approximately 52% of regional product demand, while Food Grade represents around 37%. Around 30% of future market-development activity is expected to focus on local formulation capability, imported ingredient distribution, and food fortification. Regional demand is expected to increase gradually through 2035 as healthcare manufacturing and nutrition-oriented food production expand across major urban markets.

Middle East & Africa

The Middle East & Africa account for approximately 6% of global phylloquinone demand, with consumption concentrated in pharmaceutical production, imported nutritional ingredients, and selected fortified food applications. Pharmaceutical uses represent approximately 54% of regional demand, while Food accounts for around 34%. More than 50% of higher-purity phylloquinone requirements in several markets depend on imported supply because local specialized vitamin manufacturing capacity remains comparatively limited.

Pharma Grade represents approximately 53% of regional product demand, while Food Grade accounts for around 35%. Approximately 28% of expected growth is associated with pharmaceutical manufacturing, fortified nutrition, and improved access to standardized vitamin ingredients. Demand is expected to increase gradually through 2035 as healthcare infrastructure, food-processing capability, and specialized ingredient distribution continue developing across major urban and industrial centers.

List of Top Phylloquinone Companies

• Nutrilo
• DSM
• BASF
• Yongan Pharmceutical
• Shandong Guangtongbao Pharmaceuticals
• Anhui Wanhe Pharmaceutical
• Zhejiang Chengyi Pharmaceutical

Top 2 Companies Market Share

DSM: DSM is estimated to account for approximately 18% of competitive market participation, supported by extensive nutritional ingredient expertise, global distribution, advanced formulation capabilities, and strong quality-management systems. Its position is reinforced by demand for Pharma Grade phylloquinone, which represents approximately 56% of the market, and by increasing customer focus on potency verification, stability, documentation, and application-specific performance.

BASF: BASF is estimated to represent approximately 15% of competitive market participation, supported by large-scale manufacturing capabilities, technical formulation expertise, and established relationships across food and pharmaceutical value chains. Approximately 42% of competitive investment is directed toward purification, analytical testing, stabilization, and manufacturing modernization, aligning closely with the company’s strengths in controlled processing and technical product development.

Investment Analysis

Investment activity in the phylloquinone market is increasingly directed toward purification, process automation, analytical testing, encapsulation, oxidation protection, and pharmaceutical-grade manufacturing. Approximately 43% of new capacity-oriented investment is concentrated in Asia-Pacific because the region combines expanding pharmaceutical production, growing food fortification activity, and improving specialized ingredient manufacturing capabilities. Around 35% of technical capital allocation is focused on stabilization and protective delivery technologies designed to maintain potency during processing, transportation, and storage. Pharma Grade remains an important investment priority because it accounts for approximately 56% of product demand and requires tighter impurity control, validated potency, and stronger documentation than less regulated grades.

Capital allocation is also shifting toward quality assurance, traceability, and application-specific formulation capabilities rather than simple capacity expansion. Approximately 42% of competitive investment is directed toward purification, analytical verification, stability improvement, and manufacturing modernization. Around 37% of formulation-related difficulties are associated with oxidation, light sensitivity, temperature exposure, and potency retention, making protective packaging and stabilized delivery systems increasingly important investment areas. Producers capable of combining scalable manufacturing with rigorous quality systems, advanced stabilization technology, and dependable distribution are expected to attract stronger long-term investment as the market advances at a projected 6.1% CAGR.

New Product Development

New product development in the phylloquinone market increasingly focuses on stabilized, encapsulated, and application-specific vitamin K1 formats that provide improved resistance to oxidation, light, heat, and formulation interactions. Approximately 39% of current product-development activity is associated with fortification compatibility, improved dispersibility, standardized potency, or specialized nutritional formulations. Food Grade products are being optimized for greater stability across processed food systems, while Pharma Grade products are increasingly developed with tighter analytical specifications and enhanced packaging protection. Pharmaceutical applications remain the largest development target with approximately 52% of demand, encouraging continued emphasis on precise potency and validated manufacturing consistency.

Food applications, representing approximately 36% of demand, are also becoming an important area for innovation as manufacturers seek easier-to-use vitamin K1 systems for fortified and specialized nutritional products. Around 40% of food-focused buyers emphasize stability, uniform dispersion, and accurate concentration, creating opportunities for improved emulsified, encapsulated, or carrier-based products. Other applications, which account for approximately 12% of demand, provide additional room for customized concentration and delivery formats. Through 2035, product development is expected to favor phylloquinone systems that combine stable potency, formulation flexibility, reliable quality documentation, and efficient integration into pharmaceutical and food manufacturing processes.

Five Recent Developments

• July 2026: Phylloquinone manufacturers expanded stabilization and encapsulation programs to improve vitamin K1 resistance to oxidation, light exposure, and storage-related degradation. Approximately 35% of technical development activity is focused on protective delivery systems, controlled carriers, improved emulsification, and packaging performance across pharmaceutical and food formulations.
• March 2026: Asia-Pacific producers accelerated investment in pharmaceutical-grade purification, analytical testing, and quality-control infrastructure. Approximately 43% of new capacity-oriented investment is concentrated in the region, supporting stronger local manufacturing capabilities for Pharma Grade phylloquinone and more consistent supply to domestic and export customers.
• November 2025: Food and nutrition manufacturers increased development of fortified products using more stable vitamin K1 ingredients. Food applications account for approximately 36% of market demand, while around 40% of food-focused buyers emphasize dispersion quality, potency accuracy, and storage stability when selecting phylloquinone ingredients.
• June 2025: Pharmaceutical ingredient suppliers strengthened analytical verification, impurity control, and batch documentation as buyer qualification requirements became more rigorous. Approximately 53% of pharmaceutical-oriented buyers prioritize potency verification, storage stability, traceability, and impurity control when evaluating Pharma Grade phylloquinone suppliers.
• September 2024: Producers increased focus on protective packaging and controlled storage systems to preserve product potency during distribution. Approximately 37% of formulation-related difficulties are associated with oxidation, light sensitivity, temperature variation, and potency retention, encouraging greater investment in stability-oriented packaging technologies and logistics management.

Report Coverage

The Phylloquinone Market report evaluates industry conditions across the 2025 base period, the 2026 transition year, and the forecast horizon extending through 2035. Market activity is projected to increase approximately 93.9% between 2025 and 2035, supported by expanding pharmaceutical manufacturing, food fortification, micronutrient awareness, and wider use of standardized vitamin K1 ingredients. Product coverage includes Food Grade, Pharma Grade, and Other, with individual shares estimated at approximately 34%, 56%, and 10%. The analysis evaluates how purity, potency consistency, oxidation resistance, light stability, formulation compatibility, analytical verification, packaging, and storage conditions influence product selection. Application coverage includes Food, Pharmaceutical, and Other, with individual shares estimated at approximately 36%, 52%, and 12%. Particular attention is given to Pharmaceutical applications because they remain the largest demand segment and require tighter quality control, documentation, impurity limits, and potency consistency.

Regional analysis covers North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa, with individual shares estimated at approximately 22%, 24%, 41%, 7%, and 6%. Competitive coverage includes Nutrilo, DSM, BASF, Yongan Pharmceutical, Shandong Guangtongbao Pharmaceuticals, Anhui Wanhe Pharmaceutical, and Zhejiang Chengyi Pharmaceutical. The report also evaluates purification technology, encapsulation, oxidation protection, analytical testing, pharmaceutical-grade processing, food fortification, regional capacity investment, and quality-control modernization. With market activity projected to increase approximately 82.7% between 2026 and 2035, competitive performance is expected to depend increasingly on stable potency, efficient purification, protective delivery technologies, rigorous documentation, and the ability to serve increasingly specialized Food, Pharmaceutical, and Other applications.